Signs of Low Testosterone and When To Consider TRT

Table of Contents

Low testosterone can cause a range of physical, sexual, and psychological symptoms, including fatigue, reduced sex drive, loss of muscle mass, and mood changes. Because many of these symptoms overlap with those of other conditions, such as thyroid disorders, depression, and sleep apnea, a confirmed diagnosis requires blood testing alongside a full medical evaluation. This article explains the symptoms of low testosterone, how they are assessed, and the diagnostic process.

At a Glance

What it is: Low testosterone (hypogonadism) is a condition in which the body produces insufficient testosterone
Common signs: Low libido, fatigue, reduced muscle mass, mood changes, and difficulty concentrating
Key qualifier: Symptoms alone are not sufficient for diagnosis and often overlap with other conditions
Diagnosis: Requires blood testing and clinical evaluation
When to act: Persistent or multiple symptoms require prompt medical evaluation
Key misconception: Not all symptoms of aging are caused by low testosterone

What Is Low Testosterone?

Hypogonadism is the medical term for a condition in which the body does not produce enough testosterone to maintain normal health and function. Although testosterone plays a role in all bodies, it is the primary male sex hormone. In men, it regulates sex drive, sperm production, bone density, fat distribution, muscle mass, red blood cell production, and mood.

Testosterone levels naturally decline with age, but clinical deficiency is distinct from normal aging. A gradual, modest decrease in testosterone over decades is expected. Hypogonadism, by contrast, involves levels low enough to cause measurable symptoms and health consequences. It can occur at any age, not just in older adults.

Low testosterone (hypogonadism): A clinical condition in which the body produces insufficient testosterone. This is confirmed by repeated blood tests showing levels below the normal reference range combined with the presence of characteristic signs and symptoms. It is a medical diagnosis, not a natural stage of aging.

What Causes Low Testosterone?

The causes¹ of low testosterone fall into two broad categories: primary and secondary hypogonadism. Primary hypogonadism originates in the testes themselves. The glands are damaged, underdeveloped, or otherwise unable to produce adequate testosterone. Secondary hypogonadism originates in the brain. The hypothalamus and pituitary gland cannot send proper signals to the testes to produce testosterone.

Common causes of primary hypogonadism include Klinefelter syndrome, undescended testicles, testicular injury or infection (such as mumps orchitis), and prior cancer treatment involving radiation or chemotherapy. Secondary hypogonadism can result from pituitary tumors or disorders, Kallmann syndrome, inflammatory diseases affecting the pituitary, and certain medications, such as long-term opioid use and glucocorticoids.

Several factors contribute to low testosterone across both categories. Obesity is a major modifiable risk factor. Excess adipose tissue increases the conversion of testosterone to estrogen. Chronic illnesses, including type 2 diabetes, HIV/AIDS, liver disease, and kidney disease, are associated with reduced testosterone production. Obstructive sleep apnea, excessive alcohol use, and metabolic syndrome are other risk factors.It is worth noting that testosterone declines² naturally at a rate of about 1% per year after age 35. This gradual reduction does not automatically result in hypogonadism. Age-related decline is a normal biological process, while clinical deficiency is diagnosed using specific laboratory and symptom criteria.

Signs and Symptoms of Low Testosterone

The symptoms of low testosterone span sexual, physical, cognitive, and emotional domains. Recognizing how these symptoms cluster together, rather than evaluating any single symptom in isolation, is more clinically meaningful when deciding whether testing is warranted.

Low libido and erectile dysfunction. Reduced interest in sex is one of the most commonly reported symptoms of low testosterone in men. Testosterone plays a direct role in sexual desire, and a significant decline can diminish libido noticeably. Erectile dysfunction may also occur, but it is rarely a direct result of low testosterone. Instead, it is often caused by several factors.³ Examples include cardiovascular disease, diabetes, medications, and psychological conditions. Low testosterone alone accounts for only a minority⁴ of erectile dysfunction cases.

Fatigue and reduced energy. Persistent, unexplained fatigue, the kind that does not improve with adequate sleep, is frequently associated with low testosterone. People with clinically low levels often describe a baseline lack of energy or motivation that affects work, exercise tolerance, and daily activities.

Loss of muscle mass and increased body fat. Testosterone supports lean muscle maintenance and influences fat distribution. Men with low testosterone may notice decreased muscle strength, reduced muscle size despite consistent activity, or increased abdominal fat. These body composition changes can develop gradually, making them easy to attribute to aging alone.

Mood changes, depression, and difficulty concentrating. Irritability, depressed mood, reduced motivation, and cognitive difficulties, such as poor concentration or memory complaints, are common symptoms of low testosterone. These overlap substantially with symptoms of clinical depression, anxiety disorders, sleep disorders, and thyroid conditions. This is precisely why symptom-based diagnosis is unreliable.

Reduced bone density. Testosterone contributes to bone mineral density. Chronic, untreated hypogonadism is associated with osteopenia and osteoporosis, increasing fracture risk over time. This effect is gradual and may not be noticed until a fracture occurs.

Many of these symptoms overlap with other common medical conditions. Fatigue can stem from anemia, hypothyroidism, sleep apnea, or depression. Mood changes may reflect psychiatric conditions, stress, or medication side effects. Erectile dysfunction is frequently vascular or neurological in origin. Any of these symptoms has multiple possible explanations, which is why laboratory testing is essential before attributing symptoms to low testosterone.

When Should You Be Concerned About Symptoms?

Not every instance of fatigue, low mood, or reduced libido signals a hormonal problem. The clinical significance of symptoms depends on their persistence, their number, and their effect on daily life.

Persistent vs. occasional symptoms. A week of poor sleep resulting in fatigue is not the same as months of unexplained, unrelenting exhaustion. Occasional dips in libido are normal; a sustained absence of sexual interest over weeks or months is more concerning. If symptoms persist despite adequate sleep, low stress, and general health maintenance, then further medical evaluation is recommended.

Multiple symptoms vs. isolated symptoms. A single symptom, even a persistent one, is less suggestive of low testosterone than a cluster of symptoms occurring together. When someone experiences reduced libido alongside persistent fatigue, increased body fat, and mood changes simultaneously, the pattern becomes more clinically relevant. Isolated symptoms are more likely to have non-hormonal explanations.

Impact on daily functioning. Symptoms worth evaluating are those that interfere with overall quality of life. If fatigue prevents normal activities, if mood changes strain relationships, or if sexual dysfunction causes significant distress, these functional impacts strengthen the case for medical evaluation.

Duration and progression. Symptoms that develop gradually over months and progressively worsen, rather than fluctuating with life circumstances, are more consistent with an underlying hormonal or medical condition. Acute onset of symptoms, particularly in younger men, may suggest a different etiology and may warrant prompt evaluation.

The goal is not to self-diagnose based on a checklist but to recognize when a pattern of symptoms becomes significant enough to consult with a healthcare provider. Persistent symptoms that last more than several weeks, involve more than one domain (sexual, physical, cognitive, or emotional), and affect daily functioning are reasons to see a healthcare provider.

How Is Low Testosterone Diagnosed?

Diagnosing low testosterone⁵ is a structured clinical process. It requires both laboratory confirmation and documented symptoms. Neither alone is sufficient.

Step 1: Clinical evaluation. A provider begins with a thorough medical history and physical examination. This includes reviewing symptoms, their duration and severity, medication use, medical conditions, sleep quality, and lifestyle factors. The physical exam may assess testicular size, body hair distribution, breast tissue, and body composition.

Step 2: Morning blood testing. Testosterone levels follow a circadian rhythm, peaking in the early morning. Blood samples⁶ should be drawn between 7:00 AM and 10:00 AM to capture the most accurate reading. The American Urological Association (AUA) recommends at least two morning measurements on separate days to confirm consistently low levels.

Step 3: Interpreting results. The AUA defines low testosterone as a total testosterone level below approximately 300 ng/dL. However, this threshold is not absolute. Some men experience symptoms at levels just above this cutoff, while others with levels below it experience few symptoms. Free testosterone and bioavailable testosterone levels are measured when total testosterone is borderline or in conditions affecting sex hormone-binding globulin (SHBG),⁷ the protein that binds testosterone in the blood.

Step 4: Additional laboratory work. Depending on initial results, providers may order additional tests to determine the cause and rule out other conditions. Luteinizing hormone (LH) levels help with differentiating primary from secondary hypogonadism. A follicle-stimulating hormone (FSH) level is ordered before starting treatment for hypogonadism. Other tests include prolactin levels, thyroid function tests, complete blood count, metabolic panel, and pituitary MRI.

Step 5: Confirming diagnosis. A diagnosis of hypogonadism requires both confirmed low testosterone on repeated morning testing and the presence of clinically significant signs or symptoms. Low lab values without symptoms, or symptoms without confirmed low values, do not meet diagnostic criteria for treatment under current clinical guidelines.

Who Should Consider TRT?

Testosterone replacement therapy (TRT) may be considered for individuals with confirmed symptomatic hypogonadism. This means both laboratory-confirmed low testosterone on repeated testing and the presence of clinically meaningful symptoms.

TRT is not appropriate for individuals with normal testosterone levels who happen to experience fatigue or reduced libido. Nor is it indicated as a preventive measure or performance enhancer. The Endocrine Society clinical practice guidelines⁸ specify that testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics, to improve sexual function, sense of well-being, bone mineral density, and body composition.

Treatment decisions involve weighing expected benefits against potential risks, considering the patient’s overall health, fertility goals, cardiovascular history, and underlying cause of low testosterone. The decision is collaborative and is made between the patient and a qualified healthcare provider, rather than based on lab values or symptoms alone.

When TRT May Not Be Appropriate

Several situations make TRT inadvisable or require careful reconsideration.

Contraindications. Current clinical guidelines identify specific contraindications⁹ to testosterone therapy. These include breast or prostate cancer (current or prior history in some cases), untreated severe obstructive sleep apnea, uncontrolled heart failure, a hematocrit above 50% (elevated red blood cell concentration), and desire for near-term fertility. Testosterone therapy suppresses sperm production, so men who wish to conceive should discuss alternative approaches with their provider.

Performance enhancement. Using testosterone to enhance athletic performance, increase muscle mass in the absence of deficiency, or counteract normal aging is not a medically sanctioned use. Supraphysiological doses¹⁰ carry significant health risks and fall outside the scope of legitimate hormone replacement.

Borderline cases and reversible causes. When testosterone levels are borderline and symptoms are mild, lifestyle modifications may be more appropriate as a first step. Weight loss in obese men, treatment of sleep apnea, management of chronic conditions like diabetes, reduction of alcohol intake, discontinuation of offending medications, and improved sleep hygiene have all been shown to raise testosterone levels in some individuals. Addressing reversible causes before starting lifelong hormone therapy is a reasonable approach, especially for younger patients.

What Happens If Low Testosterone Goes Untreated?

Untreated hypogonadism is associated with several potential long-term health consequences, though individual outcomes vary considerably.

Bone density decline. Chronic testosterone deficiency can reduce bone mineral density over time. This can progress to osteopenia or osteoporosis and increase the risk of fractures, particularly vertebral and hip fractures.

Body composition changes. Without adequate testosterone, lean muscle mass tends to decrease while visceral fat accumulates. These changes can compound metabolic risk factors and reduce physical function.

Metabolic associations. Low testosterone has been associated with insulin resistance, metabolic syndrome, and type 2 diabetes in observational studies,¹¹ though the directionality of these relationships is not fully resolved. Obesity can cause low testosterone, which, in turn, may worsen metabolic health, creating a feedback loop.

Sexual health decline. Persistent low libido and erectile dysfunction can worsen without treatment, affecting relationships and psychological well-being.

Mood and cognitive effects. Some studies suggest that untreated low testosterone is associated with increased risk of depressive symptoms¹² and cognitive decline, though these findings are not universal due to factors that are difficult to control for in research.

Not every person with untreated low testosterone will experience most of these outcomes. The severity of deficiency, its duration, the underlying cause, and a person’s overall health all influence outcomes.

How Does Testosterone Replacement Therapy Work?

TRT works by providing exogenous (externally sourced) testosterone to restore blood levels to the normal physiological range. It does not cure or fix the underlying cause of low testosterone. If the testes or pituitary are not producing adequate testosterone, TRT compensates for that deficit but does not repair the dysfunction itself.

An important physiological consequence: exogenous testosterone suppresses the body’s own production. The hypothalamic-pituitary-gonadal axis responds to adequate blood testosterone levels by reducing signaling to the testes, leading to a decrease or cessation of natural testosterone production and sperm production. Choosing to use TRT is a long-term commitment and requires medical guidance, especially during discontinuation of TRT.

The goal of therapy⁵ is to bring testosterone levels into the mid-normal range of 450-600 ng/dL. This is enough to relieve symptoms without exceeding physiological levels. Dosing is individualized and adjusted based on lab monitoring and symptom response.

Types of Testosterone Replacement Therapy

Several delivery methods are available for TRT. Each has distinct characteristics regarding convenience, consistency of levels, cost, and side effect profiles. The choice depends on patient preference, lifestyle, and clinical considerations.

Delivery Method	How It Works	Frequency	Key Advantages	Key Drawbacks
Intramuscular injections	Testosterone cypionate or enanthate injected into muscle; patients can self-administer after training	Typically every 1 to 2 weeks, though some clinicians prescribe more frequent smaller doses to reduce hormone fluctuations	Most commonly used; least expensive option	Fluctuating levels with peaks and troughs; some patients notice mood or energy swings
Topical gels	Applied to shoulders, upper arms, or abdomen; absorbed through skin	Daily	Relatively steady hormone levels	Risk of accidental transfer to women or children, which can cause serious hormone-related effects.
Transdermal patches	Patches deliver testosterone through the skin at a controlled rate	Daily	Controlled, steady delivery	Unavailable in the United States since 2023, when the sole manufacturer discontinued the only approved product¹³
Subcutaneous pellets	Small pellets implanted under the skin (typically in the hip or buttock) during a minor in-office procedure	Every 3 to 6 months	Consistent levels without daily or weekly dosing	Requires minor procedure; occasional pellet extrusion; difficult to adjust dose once placed
Oral formulations	Testosterone undecanoate¹⁴, FDA-approved; absorbed through the lymphatic system rather than the liver, which avoids the toxicity issues seen with older oral testosterone	Twice daily, with food	Does not carry the same liver-toxicity concerns as older oral testosterone products	Older formulations linked to liver toxicity; must be taken with food twice daily

No single delivery method is universally superior. Providers and patients should discuss the trade-offs of each option in the context of individual circumstances.

What to Expect After Starting TRT: A Clinical Timeline

Symptom improvement⁵ on TRT does not happen overnight. Different symptoms respond on different timescales, and expectations should be calibrated accordingly.

Early changes (weeks 3–6). Improvements in energy, mood, and sexual interest are often among the first changes patients notice, typically within the first three to six weeks. These early improvements can be subtle and may fluctuate as dosing is adjusted.

Intermediate changes (months 3–6). Body composition changes,¹⁵ including increased lean mass and reduced fat mass, generally become apparent over three to six months of consistent therapy. Improvements in erectile function, bone density contributions, and more stable mood regulation tend to develop over this period as well.

Ongoing adjustment and monitoring. TRT requires regular follow-up. Providers typically check testosterone levels, hematocrit, PSA (prostate-specific antigen), and lipid panels at regular intervals at three months, six months, and then annually. Dose adjustments are common in the first year as the provider works to find the level that best manages symptoms while minimizing side effects. Symptom response, not just lab values, guides management.

Patients should understand that TRT is not a quick fix. It is a sustained medical therapy that requires patience, monitoring, and ongoing communication with a healthcare provider.

Risks and Side Effects of Testosterone Replacement Therapy

Like any medical therapy, TRT carries risks¹⁰ and potential side effects.⁸ These should be weighed against expected benefits as part of an informed treatment decision.

Common side effects. Acne, oily skin, and fluid retention are among the most frequently reported side effects. Injection site pain or irritation at gel or patch application sites can also occur. Many of these are mild and manageable with dose adjustment.

Polycythemia.¹⁶ TRT stimulates red blood cell production, which can raise hematocrit (the percentage of blood volume occupied by red cells) to unsafe levels. Elevated hematocrit increases blood viscosity and the risk of thromboembolic events such as stroke or deep vein thrombosis. Regular blood monitoring is essential. Hemoglobin levels above 16 g/dL and hematocrit levels above 54% typically prompt dose reduction or temporary discontinuation.

Fertility impact. Exogenous testosterone suppresses gonadotropin secretion, which reduces or stops sperm production. This effect can persist for months after discontinuation and may not be fully reversible in all cases. Men who wish to preserve fertility should discuss this with their provider before starting TRT. Alternative agents¹⁷ such as clomiphene citrate or human chorionic gonadotropin (hCG) may be considered in these situations.

Prostate considerations. The relationship between testosterone and prostate cancer has been studied extensively. Current evidence¹⁸ does not support the older belief that TRT causes prostate cancer, but guidelines⁵ recommend monitoring PSA levels and performing digital rectal examinations before and during therapy only for men with a high risk for prostate cancer. Men with active prostate cancer should not receive TRT. The evidence regarding TRT in men with a history of treated prostate cancer is evolving, and decisions in this population require specialist input.

Cardiovascular considerations. Data on cardiovascular risk¹⁹ and TRT have been mixed. Some earlier studies suggested increased cardiovascular events, while more recent large-scale trials²⁰have not confirmed a clear increase in risk for men with confirmed hypogonadism receiving appropriately dosed therapy. Current guidelines recommend cardiovascular risk assessment before initiating treatment and ongoing monitoring during therapy.

Dependency and discontinuation. Because TRT suppresses endogenous production, stopping therapy abruptly can result in a period of very low testosterone levels and symptom recurrence. Discontinuation should be managed under medical supervision. Some degree of recovery of natural production is possible, but timelines and completeness vary.

Frequently Asked Questions

The most common signs include reduced sex drive, persistent fatigue that does not improve with rest, loss of muscle mass, increased body fat, mood changes, such as irritability or depression, and difficulty concentrating. If you are experiencing several of these symptoms together over a period of weeks or months, it may be worth discussing with a healthcare provider.

Testosterone naturally declines at roughly 1% per year after age 35, but this gradual decline does not automatically mean you have a clinical deficiency. Hypogonadism can occur at any age, including in younger men, if an underlying condition is present. You should focus less on age and more on whether you are experiencing persistent, bothersome symptoms that affect your quality of life.

You cannot reliably tell from symptoms alone. Fatigue, low mood, weight gain, and reduced libido are common across many conditions, including thyroid disorders, depression, sleep apnea, and diabetes. The only way to determine whether low testosterone is the cause is through blood testing combined with a clinical evaluation by your healthcare provider.

Yes. Symptoms alone are not sufficient for diagnosis. Current guidelines require at least two morning blood tests drawn between 7:00 and 10:00 AM on separate days showing total testosterone below approximately 300 ng/dL, along with documented symptoms. Without lab confirmation, a diagnosis of hypogonadism cannot be made and treatment should not be initiated.

It depends on the cause. If your low testosterone is related to a reversible factor, such as obesity, medication use, untreated sleep apnea, or excessive alcohol consumption, addressing that factor can sometimes restore levels to the normal range. However, if the cause is a permanent condition affecting the testes or pituitary gland, levels are unlikely to normalize without treatment.

The American Urological Association⁵ defines low testosterone as a total testosterone level below approximately 300 ng/dL. However, this number is not a rigid cutoff. Some men experience symptoms at levels slightly above this threshold, while others at levels just below it may feel fine. Your provider will interpret your results in the context of your symptoms, overall health, and additional lab findings.

Untreated low testosterone may contribute to progressive bone density loss, unfavorable body composition changes, ongoing sexual dysfunction, and persistent mood or cognitive difficulties over time. These effects are not guaranteed and vary considerably between individuals. However, confirmed hypogonadism is a treatable condition, and leaving it unaddressed when it is causing symptoms and health consequences is generally not advisable.

TRT is generally recommended when you have confirmed symptomatic hypogonadism and the underlying cause is not readily reversible. If your testosterone is borderline or your symptoms are mild or due to a reversible factor, such as obesity, your provider may recommend lifestyle changes first. Weight loss, improved sleep, exercise, and management of chronic conditions can significantly improve testosterone levels in some cases.

Conclusion

Low testosterone, or hypogonadism, is a clinical condition defined by insufficient testosterone production combined with symptoms such as reduced libido, persistent fatigue, loss of muscle mass, mood changes, and reduced bone density. Symptoms alone do not confirm the diagnosis, but rather laboratory testing and a thorough clinical evaluation are required. Many symptoms attributed to low testosterone overlap with other common and treatable conditions, making professional evaluation essential.

Treatment with testosterone replacement therapy (TRT) is appropriate for individuals with confirmed symptomatic hypogonadism. It is not indicated for normal aging, performance enhancement, or borderline cases that may respond to lifestyle changes. Anyone experiencing persistent or multiple symptoms that affect daily functioning should consult a qualified healthcare provider as the appropriate next step.

References

Sizar O, Leslie SW, Schwartz J. Male Hypogonadism. StatPearls. Updated Feb 25, 2024. Accessed April 23, 2026. https://www.ncbi.nlm.nih.gov/books/NBK532933/
Cheng H, Zhang X, Li Y, et al. Age-related testosterone decline: mechanisms and intervention strategies. Reprod Biol Endocrinol. 2024;22(1):144. Published 2024 Nov 14. doi:10.1186/s12958-024-01316-5
Leslie SW, Sooriyamoorthy T. Erectile Dysfunction. StatPearls. Updated January 9, 2024. Accessed April 23, 2026. https://www.ncbi.nlm.nih.gov/books/NBK562253/
Rajfer J. Relationship between testosterone and erectile dysfunction. Rev Urol. 2000;2(2):122-128. https://pmc.ncbi.nlm.nih.gov/articles/PMC1476110/
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
Testosterone Levels Test. MedlinePlus. Updated June 5, 2025. Accessed April 23, 2026. https://medlineplus.gov/lab-tests/testosterone-levels-test/
SHBG Blood Test. MedlinePlus. Updated January 12, 2026. Accessed April 23, 2026. https://medlineplus.gov/lab-tests/shbg-blood-test/
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://academic.oup.com/jcem/article/95/6/2536/2597900
Osterberg EC, Bernie AM, Ramasamy R. Risks of testosterone replacement therapy in men. Indian J Urol. 2014;30(1):2-7. doi:10.4103/0970-1591.124197 https://pmc.ncbi.nlm.nih.gov/articles/PMC3897047/
Muraleedharan V, Jones TH. Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab. 2010;1(5):207-223. doi:10.1177/2042018810390258
Walther A, Breidenstein J, Miller R. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019;76(1):31–40. doi:10.1001/jamapsychiatry.2018.2734
Jensen L. Drug Shortage Detail: Testosterone Transdermal System. ASHP. Published March 13, 2023. Accessed April 23, 2026. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=925
Rosen SH, Asanad K. Treatment of Symptomatic Male Hypogonadism with New Oral Testosterone Therapies: A Comparative Review of Jatenzo, Tlando, and Kyzatrex. Medicines (Basel). 2025;13(1):1. Published 2025 Dec 22. doi:10.3390/medicines13010001
Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39(9):967-981. https://link.springer.com/article/10.1007/s40618-016-0480-2
Pillai AA, Kaur A, Mukkamalla SKR. Polycythemia. StatPearls. Updated February 15, 2026. Accessed April 23, 2026. https://www.ncbi.nlm.nih.gov/books/NBK526081/
Fink J, Ide H, Horie S. Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy. Medicina (Kaunas). 2024;60(2):275. Published 2024 Feb 5. doi:10.3390/medicina60020275
Bhasin S, Travison TG, Pencina KM, et al. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(12):e2348692. Published 2023 Dec 1. doi:10.1001/jamanetworkopen.2023.48692
FDA issues class-wide labeling changes for testosterone products. FDA. Published February 28, 2025. Accessed April 23, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-issues-class-wide-labeling-changes-testosterone-products
Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://www.nejm.org/doi/full/10.1056/NEJMoa2215025